CANESSA REMO

CFO Remo Canessa sold 3.7K ZS shares at $199.15; retains 213.7K shares, stock down 6.1% in 30 days.

Canessa sold 3,721 shares at $199.15 on 2025-03-18, representing a -1.7% reduction from his pre-transaction holdings of 217,423 shares. The sale occurred near the 52-week high ($216.87), with the stock now trading at $203.55, down 6.1% over 30 days and 8.6% higher over 90 days. His same-ticker history at ZS shows a poor pattern: 0 of 5 prior sells were well-timed at the 90-day horizon, with recent December 2024 sells followed by stock declines of 5.9% to 6.4%, but earlier September 2024 sales preceded gains of 11.8% to 12.2%. His cross-ticker track record shows more favorable outcomes (90-day well-timed rate 55.00%, avg 90d return +6.6%), but this specific ticker demonstrates inconsistent execution. The sale occurs as the company remains unprofitable (net income of $-7.7M in the latest quarter) despite strong revenue growth of 34.1%, adding a layer of fundamental caution to the discretionary reduction in holdings.

CFO Remo Canessa sells 6,915 shares at blended average $200.03 for $1,383,177.30 at ZS

CFO Remo Canessa executed 3 separate sales totaling 6,915 shares for $1,383,177.30 on December 17-18, 2024, at a blended average price of $200.03. The current price of $183.21 represents a -28.1% decline from the 52-week high of $254.93, positioning these sales near the recent highs of the trading range. Across his same-ticker trade history at ZS (5 prior sales), Canessa's timing has been mixed, with 3 of 5 prior sales showing strong positive 90-day returns (ranging from +10.2% to +19.3%), indicating his ZS sales have not consistently preceded stock declines. The company is unprofitable on a full-year basis (net income $-12.1M) despite strong annual revenue growth of +34.1%, which may reflect market uncertainty about profitability trajectory independent of the CFO's transaction signal.

CFO Canessa Remo sold 15,910 shares of ZS for $2.7M across three transactions Sept 17-18; stock down 13.8% in 30d and -33.9% from high.

Canessa Remo, Chief Financial Officer of Zscaler, executed 3 separate sales totaling 15,910 shares for $2,711,792.65 over two days (Sept 17-18) at blended average price $170.45, reducing holdings by 6.6% from 240,248 to 224,338 shares. This liquidity event occurs during a period of significant stock weakness: the current price of $168.52 sits -33.9% from the 52-week high of $254.93 and -13.8% over the prior 30 days. Notably, Canessa's prior 2 measurable sells at this same ticker (June 2024) achieved 90-day returns of -4.8% and -4.3%, indicating a pattern of well-timed exits before subsequent declines. The company's fundamentals show elevated valuation risk—trading at a P/E of 358.55 despite negative full-year net income, though annual revenue growth remains strong at 34.1%—providing context for why the CFO's liquidation activity merits investor attention during this period of price deterioration.

Zscaler CFO Remo Canessa sold 15,908 shares for $2,837,579.14 across 9 transactions June 18–21, 2024.

Remo Canessa, Zscaler's CFO, executed 9 separate sales totaling 15,908 shares for $2,837,579.14 over three trading days at prices ranging from $176.13 to $180.93, with a blended average of $178.37. The sale reduced his holdings from 256,156 shares to 240,248 shares, representing a -6.2% reduction. At the same-ticker level, his prior 5 sells at ZS yielded a 40% well-timed rate (2 of 5); by contrast, his cross-ticker track record across 18 prior sells shows only an 11.11% well-timed rate at the 90-day mark, with an average 90-day return of +22.2% after his sells—suggesting his historical sales have generally preceded stock appreciation rather than declines. The company reported FY revenue growth of +48.2% and has shown strong quarterly revenue ($553.2M), but remains unprofitable on a full-year basis with FY net income negative, despite recent quarterly net income of $19.1M. The current price of $179.55 is -29.6% from the 52-week high of $254.93 and down -7.9% over 90 days, placing the sale within a period of elevated volatility. Without timeline flags (scheduled 10b5-1 plan or otherwise), the pattern invites scrutiny of whether CFO-level capital deployment signals reflect evolving conviction, though the limited same-ticker track record at this executive level leaves the interpretation ambiguous.